WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention : use of mRNA tests for human papillomavirus (HPV).Second edition / World Health Organization.

Format:

Book

Author/Creator:

World Health Organization, author, issuing body.

Language:

English

Subjects (All):

Medical screening.

Cervix uteri--Cancer.

Cervix uteri.

Physical Description:

1 online resource (xvi, 51 pages) : illustrations

Edition:

2nd ed.

Other Title:

WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention

Place of Publication:

Geneva, Switzerland : World Health Organization, 2021.

Contents:

Intro

Contents

Acronyms and abbreviations

Acknowledgements

Executive summary

Background

Methods

1. Introduction

1.1 Background

1.2 Approaches to screening and treatment

1.3 Rationale for this new edition of recommendations

1.4 Phased approach for the development of the recommendations

1.5 Target audience

2. Methods

2.1 Groups contributing to the guideline development process

Declarations and management of conflicts of interest

Confidentiality

2.2 Scoping review and appraisal of the existing recommendations

2.3 Priority questions for review of evidence

2.4 Priority algorithms

2.5 Outcomes

2.6 Syntheses of evidence

2.6.1 Methods used for systematic literature reviews

3. Important considerations for the recommendations

3.1 Programme considerations

3.2 Screening and triage tests considered in these guidelines

References

Annexes

Annex 1: Guideline groups

Annex 2. Evidence-gathering teams and guideline task groups

Annex 3. Declarations of interests

Annex 4. Seven algorithms prioritized for Phase 1 of the guideline update

Annex 5. Standardized definitions used in this guideline

Summary of recommendations for the use of HPV mRNA testing to prevent cervical cancer

1.2 HPV mRNA technology and interpretation of test results

1.3 Phased approach for development of updated recommendations and purpose of this guideline

1.5 Previous and existing WHO recommendations for screening and treatment to prevent cervical cancer and definitions

1.7 Target audience

2. Methods for development of recommendations on HPV mRNA testing

2.1. Groups contributing to the guideline development process.

2.2 Scoping review and appraisal of the existing recommendations

2.3 Priority algorithms

2.4 Outcomes

2.5 Syntheses of evidence

2.6 Development of the recommendations

2.7 Management of the external peer review

3. Recommendations on HPV mRNA testing

4. Research gaps and further considerations for HPV mRNA testing

5. Dissemination and updating of the guideline

5.1 Guideline dissemination and impact

5.2 Guideline update

Annex 1. Guideline groups

Annex 4. Algorithms for use of HPV mRNA tests in the general population of women

Annex 5. Recommendations from Phase 1 of the guideline update: HPV DNA tests and other cervical screening methods1.

Notes:

Description based on: online resource; title from PDF information screen (NCBI, viewed November 06, 2022).

Includes bibliographical references.